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7-14% of patients suffering from primary sclerosing cholangitis (PSC) may present with clinical and 
serological features, indicating an overlap syndrome with autoimmune hepatitis (AIH). In an otherwise 
indolent course of a chronic liver disease, an exacerbation can result in acute liver failure (ALF). A 22-
year-old man with a history of thrombotic events and verified thrombophilia (PAI-1 mutation) presented 
with jaundice (bilirubin=211,3 μmol/L) and abdominal discomfort. His synthetic liver function rapidly 
deteriorated (AST=3084 U/L, ALT=2928 U/L, ALP=154 U/L, GGT=63 U/L). Initial workup excluded 
viral causes and he was referred to the University Hospital Merkur with the diagnosis of ALF of 
unknown etiology. Whilst pursuing the underlying cause of the ALF and concomitant anaemia, the 
diagnosis of Crohn’s disease was established via lower endoscopy. In the following days, the patient’s 
state severely worsened, including the development of stage 3 hepatic encephalopathy. 7 days after 
admission, the patient was successfully transplanted. Histological assessment confirmed the diagnosis 
of overlapping AIH and PSC. The patient was uneventful for 2.5 years, when after the rise of liver 
enzymes (AST=296 U/L, ALT=682 U/L, GGT=93 U/L, ALP=165 U/L), a liver biopsy confirmed the 
relapse of AIH. Remission was attained with the administration of corticosteroids. In the 3-year follow-
up, the patient was relapse-free without thromboembolic events. This complex case emphasizes the 
importance of prompt management of ALF and the difficulty of distinguishing acute on chronic liver 
failure from ALF. Overlapping liver diseases can be accompanied by various conditions, most 
commonly inflammatory bowel diseases, which makes the treatment particularly challenging. 
 
 
  
